By Raj Srinivasaraghavan The cloud is enveloping more sectors, faster and deeper. Health and pharmaceuticals are exception. Rather, the two sectors have been one of the pioneers to adopt cloud and other futuristic technologies. More than being an enabler, cloud has now emerged as an inevitable technology for the sector as a whole and new … Read more
Editor’s Note: Editor’s Note: A version of this story appeared in CNN’s Meanwhile in China newsletter, a three-times-a-week update exploring what you need to know about the country’s rise and how it impacts the world. Sign up here. Hong Kong CNN — China’s zero-Covid policy, which stalled the world’s second-largest economy and sparked a wave … Read more
The announcement of two key initiatives – the National Tele Mental Health Program (slated to be launched in April 2022) and a provision to create a complete Digital Health Ecosystem, which will comprise digital registries of health providers and patient records – is testimony to the government’s commitments towards standardizing access to healthcare. By Ms … Read more
Honeywell on Monday announced digital authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products. An acute shortage of drugs to treat symptoms of Covid-19 has led to increased circulation of counterfeit medicines in recent times, a company statement said. It added that there are reports of fake antiviral medicines … Read more
What is the status of counterfeiting in the pharmaceutical industry? What is the Status in India? Is counterfeiting affecting only the pharmaceutical industry? What are the latest trends? Substandard, spurious, falsely labelled, falsified, and counterfeit medical products collectively called as SSFFC medical products are by their very nature difficult to detect. They are often designed … Read more
Mumbai: Infrastructure- and industrial-related stocks are expected to gain as India steps up spending, while pent-up demand could also boost the real estate sector, said Ridham Desai, MD, Morgan Stanley India. Staples-related consumption looks fully priced, while discretionary and travel related stocks could also be in the list of potential purchases, Desai said in a … Read more
The week gone by saw the domestic equity indices move in a wide range and stocks rally on global risk-on sentiment following the US election verdict. Not only was the trading range wide at 723 points, volatility too declined to a great extent. The market’s bias over the past five days remained secularly bullish, and … Read more
Picture for representational purpose only. November 3, 2020: 90% Pharmaceutical marketers are of the view that non-transparency of ‘doctor reach and results’ is a major bottleneck in adoption of digital in Rx drug marketing, as per a survey conducted by Doceree, the first global network of Physician-only platforms for programmatic marketing. It is a well-known … Read more
To think that pharma can continue to go the same way, especially after the kind of steep rally it has seen, is being overly bullish, says the independent market expert. What is the sense that you are getting about where the markets are headed from here? The global market movement matters much more than what … Read more
We are looking at more domestic plays in the second half of 2021 when you can start nibbling away when you get days like today, says the CEO, Avendus Capital. Where do you think we are headed given the various factors we are tracking both globally as well as right here back home?We have followed … Read more